Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Consolidated Diluted EPS At -0.4612

0

For the year ended 2015-12-31 Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) basic consolidated EPS came $-0.4612. Furthermore, for the quarter closed 2015-12-31, it was $-0.4612.

Consolidated diluted EPS

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) consolidated diluted EPS was -0.4612 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-0.4612.

EPS contribution from parent

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) basic EPS was $-0.4612 for the year ended 2015-12-31 from its parent entity. It was $-0.4612 for the quarter closed 2015-12-31.

EPS from continuing operations

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) EPS from continuing activities was $-0.4612 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-0.4612.

Basic net EPS

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) basic net EPS was $-0.46 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-0.46.

Diluted EPS from parent

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) diluted EPS from parent entity came at $-0.4612 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-0.4612.

Net diluted EPS

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) net diluted EPS was $-0.46 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-0.46.

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) net basic EPS was $-0.46 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-0.46.

Basic diluted EPS

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) basic diluted EPS was $-0.0861 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.0861.

For the year ended 2015-12-31, basic shares outstanding were 18.406 while for the quarter ended 2015-12-31 is 18.406.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 18.406 and for the quarter ended 2015-12-31 it was 18.406. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)